The nasal COVID-19 vaccine developed by scientists at WashU Medicine is set to enter another phase of clinical trials, a process that should have been completed years ago. Who knows what this vaccine’s effectiveness will be? After all, vaccine development is akin to a ‘nasal mucus battle,’ where the spray contains hope and the flow holds the unknown.
Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials
